Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of HIV-proteinase inhibitors.

× No keyword cloud information.

15 in total

Review 1. Current knowledge and future prospects for the use of HIV protease inhibitors.

Authors: G Moyle; B Gazzard
Journal: Drugs Date: 1996-05 Impact factor: 9.546

2. Rational design of peptide-based HIV proteinase inhibitors.

Authors: N A Roberts; J A Martin; D Kinchington; A V Broadhurst; J C Craig; I B Duncan; S A Galpin; B K Handa; J Kay; A Kröhn
Journal: Science Date: 1990-04-20 Impact factor: 47.728

3. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection.

Authors: M Markowitz; M Saag; W G Powderly; A M Hurley; A Hsu; J M Valdes; D Henry; F Sattler; A La Marca; J M Leonard
Journal: N Engl J Med Date: 1995-12-07 Impact factor: 91.245

4. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors.

Authors: J H Condra; W A Schleif; O M Blahy; L J Gabryelski; D J Graham; J C Quintero; A Rhodes; H L Robbins; E Roth; M Shivaprakash
Journal: Nature Date: 1995-04-06 Impact factor: 49.962

5. Human immunodeficiency virus type 1 (HIV-1) inhibitory interactions between protease inhibitor Ro 31-8959 and zidovudine, 2',3'-dideoxycytidine, or recombinant interferon-alpha A against zidovudine-sensitive or -resistant HIV-1 in vitro.

Authors: V A Johnson; D P Merrill; T C Chou; M S Hirsch
Journal: J Infect Dis Date: 1992-11 Impact factor: 5.226

6. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

Authors: W A O'Brien; P M Hartigan; D Martin; J Esinhart; A Hill; S Benoit; M Rubin; M S Simberkoff; J D Hamilton
Journal: N Engl J Med Date: 1996-02-15 Impact factor: 91.245

7. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

Authors: M A Fischl; D D Richman; M H Grieco; M S Gottlieb; P A Volberding; O L Laskin; J M Leedom; J E Groopman; D Mildvan; R T Schooley
Journal: N Engl J Med Date: 1987-07-23 Impact factor: 91.245

Review 8. HIV therapy advances. Update on a proteinase inhibitor.

Authors: S Vella
Journal: AIDS Date: 1994-09 Impact factor: 4.177

9. Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959.

Authors: H Jacobsen; K Yasargil; D L Winslow; J C Craig; A Kröhn; I B Duncan; J Mous
Journal: Virology Date: 1995-01-10 Impact factor: 3.616

10. Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase.

Authors: J C Craig; I B Duncan; D Hockley; C Grief; N A Roberts; J S Mills
Journal: Antiviral Res Date: 1991-12 Impact factor: 5.970